High Rate of Non-Eligibility: Methodological Factors Impacting on Recruitment for a Multicentre, Double-Blind Study of Paediatric Patients with Major Depressive Disorder

Pharmacopsychiatry ◽

10.1055/s-0032-1314806 ◽

2012 ◽

Vol 46 (01) ◽

pp. 23-28

Author(s):

L. Bliznak ◽

R. Berg ◽

A. Häge ◽

R. Dittmann

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Blind Study ◽

High Rate ◽

Double Blind Study ◽

Major Depressive ◽

Double Blind ◽

Paediatric Patients

Download Full-text

A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder

International Clinical Psychopharmacology ◽

10.1097/yic.0000000000000304 ◽

2020 ◽

Vol 35 (3) ◽

pp. 137-146 ◽

Author(s):

Andrea Fagiolini ◽

Umberto Albert ◽

Laura Ferrando ◽

Erik Herman ◽

Cosmina Muntean ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Extended Release ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Major Depressive ◽

Download Full-text

Randomized, Double-Blind Study of the Efficacy and Tolerability of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Elderly Patients With Major Depressive Disorder

American Journal of Geriatric Psychiatry ◽

10.1097/jgp.0b013e3182545e50 ◽

2012 ◽

pp. 1 ◽

Author(s):

Heikki Katila ◽

Irina Mezhebovsky ◽

Amy Mulroy ◽

Lovisa Berggren ◽

Hans Eriksson ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Elderly Patients ◽

Extended Release ◽

Blind Study ◽

Double Blind Study ◽

Major Depressive ◽

Double Blind ◽

Quetiapine Fumarate ◽

Download Full-text

Comparison of vortioxetine versus venlafaxine XR in adults in Asia with major depressive disorder: a randomized, double-blind study

Current Medical Research and Opinion ◽

10.1185/03007995.2015.1014028 ◽

2015 ◽

Vol 31 (4) ◽

pp. 785-794 ◽

Author(s):

Gang Wang ◽

Mette Gislum ◽

Gleb Filippov ◽

Stuart Montgomery

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Blind Study ◽

Double Blind Study ◽

Major Depressive ◽

Download Full-text

Is viloxazine an antidepressant? A placebo-controlled double-blind study in major depressive disorder presenting in a general hospital

Human Psychopharmacology Clinical and Experimental ◽

10.1002/hup.470060106 ◽

1991 ◽

Vol 6 (1) ◽

pp. 31-38 ◽

Author(s):

C. Thompson ◽

G. Isaacs

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

General Hospital ◽

Blind Study ◽

Double Blind Study ◽

Major Depressive ◽

Download Full-text

A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder

Neuropsychiatric Disease and Treatment ◽

10.2147/ndt.s50248 ◽

2014 ◽

pp. 201 ◽

Author(s):

Gang Wang ◽

Alexander McIntyre ◽

Earley ◽

Shane Raines ◽

H Eriksson

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Extended Release ◽

Blind Study ◽

Double Blind Study ◽

Major Depressive ◽

Double Blind ◽

Quetiapine Fumarate ◽

Download Full-text

A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder

Current Medical Research and Opinion ◽

10.1185/030079906x121039 ◽

2006 ◽

Vol 22 (9) ◽

pp. 1703-1713 ◽

Author(s):

C. Munizza ◽

L. Olivieri ◽

G. Di Loreto ◽

P. Dionisio

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Blind Study ◽

Prolonged Release ◽

Double Blind Study ◽

Major Depressive ◽

Download Full-text

Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder

International Clinical Psychopharmacology ◽

10.1097/00004850-200505000-00002 ◽

2005 ◽

Vol 20 (3) ◽

pp. 131-137 ◽

Author(s):

Nicholas Moore ◽

H??l??ne Verdoux ◽

Bruno Fantino

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Outpatient Treatment ◽

Blind Study ◽

Double Blind Study ◽

Major Depressive ◽

Download Full-text

A Multicenter Double-Blind Study of Three Different Doses of the New cAMP-Phosphodiesterase Inhibitor Rolipram in Patients with Major Depressive Disorder

Neuropsychobiology ◽

10.1159/000118897 ◽

1992 ◽

Vol 26 (1-2) ◽

pp. 59-64 ◽

Author(s):

W.W. Fleischhacker ◽

H. Hinterhuber ◽

H. Bauer ◽

B. Pflug ◽

P. Berner ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Phosphodiesterase Inhibitor ◽

Blind Study ◽

Double Blind Study ◽

Major Depressive ◽

Double Blind ◽

Camp Phosphodiesterase ◽

Different Doses

Download Full-text

P.2.c.026 Superior antidepressant efficacy of agomelatine vs fluoxetine in severe major depressive disorder patients: a randomised, double-blind study

European Neuropsychopharmacology ◽

10.1016/s0924-977x(09)70648-0 ◽

2009 ◽

Vol 19 ◽

pp. S418-S419 ◽

Author(s):

A. Hale ◽

R. Corral ◽

O. Mencacci ◽

J. Saiz Ruiz ◽

C. Albarran Severo ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Blind Study ◽

Double Blind Study ◽

Major Depressive ◽

Double Blind ◽

Antidepressant Efficacy

Download Full-text

Randomized, Double-Blind Study of the Efficacy and Tolerability of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Elderly Patients with Major Depressive Disorder

American Journal of Geriatric Psychiatry ◽

10.1016/j.jagp.2013.01.010 ◽

2013 ◽

Vol 21 (8) ◽

pp. 769-784 ◽

Author(s):

Heikki Katila ◽

Irina Mezhebovsky ◽

Amy Mulroy ◽

Lovisa Berggren ◽

Hans Eriksson ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Elderly Patients ◽

Extended Release ◽

Blind Study ◽

Double Blind Study ◽

Major Depressive ◽

Double Blind ◽

Quetiapine Fumarate ◽

Download Full-text